Free tool
Oncology stocks
We cover 24 companies grouped under the Oncology theme. The median market value in the group is $38.03M. Across the group, the median move over the past trading day is 0.00%. 22% of the 23 with a 200-day average trade above it. Price change over the past year runs from −72.3% to +2.6% across the middle 80 percent of the group, with a median of −35.2%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
24 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 4575.T | CanBas Co., Ltd. | 821.00 JPY | +12.47% | +0.24% | −40.51% |
| 4579.T | RaQualia Pharma Inc. | 571.00 JPY | +26.05% | −41.26% | +4.58% |
| 4888.T | Stella Pharma Corporation | 364.00 JPY | +17.42% | +71.70% | −9.23% |
| IMM.AX | Immutep Limited | 0.05 AUD | +14.89% | −87.44% | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +13.08% | −13.53% | −13.53% |
| 4572.T | Carna Biosciences, Inc. | 416.00 JPY | +40.54% | +3.48% | +83.26% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| 4597.T | Solasia Pharma K.K. | 29.00 JPY | 0.00% | +3.57% | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −15.00% | −18.07% | +58.14% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +12.77% | +8.16% | −33.75% |
| 4583.T | Chiome Bioscience Inc. | 85.00 JPY | +25.00% | −20.56% | −36.57% |
| 206A.T | PRISM BioLab Co.,LTD | 171.00 JPY | +16.33% | +6.21% | −6.56% |
| SNT.AX | Syntara Limited | 0.03 AUD | +18.18% | −23.53% | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | 75.00 JPY | 0.00% | −33.04% | −58.56% |
| 4582.T | SymBio Pharmaceuticals Limited | 63.00 JPY | −7.35% | −30.00% | −58.28% |
| IMU.AX | Imugene Limited | 0.07 AUD | −16.28% | −81.54% | −73.33% |
| NOX.AX | Noxopharm Limited | 0.09 AUD | −8.00% | −2.13% | −20.00% |
| 4882.T | Perseus Proteomics Inc. | 149.00 JPY | +2.76% | −34.65% | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | 0.01 AUD | −33.33% | −60.00% | −62.96% |
| 4598.T | Delta-Fly Pharma, Inc. | 104.00 JPY | +5.05% | −80.92% | −81.94% |
| PAB.AX | Patrys Limited | 0.03 AUD | −22.50% | +14.81% | −11.43% |
| PER.AX | PERCHERON FPO [PER] | 0.01 AUD | +25.00% | −47.37% | −54.55% |
| IVX.AX | Invion Limited | 0.04 AUD | −15.22% | −58.06% | −70.00% |
| NX1.AX | Nexalis Therapeutics Limited | 0.01 AUD | 0.00% | −50.00% | −50.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.